NCT06955273View on ClinicalTrials.gov

Multi-Centre Based Study Recognition of Atrial Fibrillation With the Corsano CardioWatch 287-2 System

Not yet recruitingOBSERVATIONAL

Enrollment

350

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

January 1, 2026

Study Completion Date

January 31, 2026

Conditions

Atrial Fibrillation (AF)Paroxysmal Atrial Fibrillation (PAF)

Interventions

DEVICE

Corsano CardioWatch 287-2

Patients receive monitoring of their heart rhythm by the CardioWatch 287-2 next to monitoring of their heart rhythm by either a 24-48 holter or a short in-clinic 12-lead ECG monitoring.

Trial Locations (1)

2625AD

Reinier de Graaf Gasthuis, Delft